Retatrutide, by Soma Pharmaceuticals , is receiving increasing attention as a potential treatment for weight regulation. This unique medication integrates the properties of a GLP-1 receptor stimulant and a GIP receptor agonist , intended to effectively promote weight loss but also improve underlying metabolic factors. Preliminary human data have sh